Table of Contents
2019-2024 Global Pemetrexed Drug Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pemetrexed Drug Market Size 2014-2024
2.1.2 Pemetrexed Drug Market Size CAGR by Region
2.2 Pemetrexed Drug Segment by Type
2.2.1 100 mg lyophilized powder/vial
2.2.2 500 mg lyophilized powder/vial
2.3 Pemetrexed Drug Market Size by Type
2.3.1 Global Pemetrexed Drug Market Size Market Share by Type (2014-2019)
2.3.2 Global Pemetrexed Drug Market Size Growth Rate by Type (2014-2019)
2.4 Pemetrexed Drug Segment by Application
2.4.1 Pleural mesothelioma
2.4.2 Non-small cell lung cancer
2.5 Pemetrexed Drug Market Size by Application
2.5.1 Global Pemetrexed Drug Market Size Market Share by Application (2014-2019)
2.5.2 Global Pemetrexed Drug Market Size Growth Rate by Application (2014-2019)
3 Global Pemetrexed Drug by Players
3.1 Global Pemetrexed Drug Market Size Market Share by Players
3.1.1 Global Pemetrexed Drug Market Size by Players (2017-2019)
3.1.2 Global Pemetrexed Drug Market Size Market Share by Players (2017-2019)
3.2 Global Pemetrexed Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers and Acquisitions, Expansion
4 Pemetrexed Drug by Regions
4.1 Pemetrexed Drug Market Size by Regions
4.2 Americas Pemetrexed Drug Market Size Growth
4.3 APAC Pemetrexed Drug Market Size Growth
4.4 Europe Pemetrexed Drug Market Size Growth
4.5 Middle East and Africa Pemetrexed Drug Market Size Growth
5 Americas
5.1 Americas Pemetrexed Drug Market Size by Countries
5.2 Americas Pemetrexed Drug Market Size by Type
5.3 Americas Pemetrexed Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pemetrexed Drug Market Size by Countries
6.2 APAC Pemetrexed Drug Market Size by Type
6.3 APAC Pemetrexed Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Pemetrexed Drug by Countries
7.2 Europe Pemetrexed Drug Market Size by Type
7.3 Europe Pemetrexed Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East and Africa
8.1 Middle East and Africa Pemetrexed Drug by Countries
8.2 Middle East and Africa Pemetrexed Drug Market Size by Type
8.3 Middle East and Africa Pemetrexed Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Pemetrexed Drug Market Forecast
10.1 Global Pemetrexed Drug Market Size Forecast (2019-2024)
10.2 Global Pemetrexed Drug Forecast by Regions
10.2.1 Global Pemetrexed Drug Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East and Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East and Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pemetrexed Drug Forecast by Type
10.8 Global Pemetrexed Drug Forecast by Application
11 Key Players Analysis
11.1 Eli Lilly and Company
11.1.1 Company Details
11.1.2 Pemetrexed Drug Product Offered
11.1.3 Eli Lilly and Company Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Eli Lilly and Company News
11.2 Pfizer
11.2.1 Company Details
11.2.2 Pemetrexed Drug Product Offered
11.2.3 Pfizer Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Pfizer News
11.3 Teva
11.3.1 Company Details
11.3.2 Pemetrexed Drug Product Offered
11.3.3 Teva Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Teva News
11.4 Eagle Pharmaceuticals
11.4.1 Company Details
11.4.2 Pemetrexed Drug Product Offered
11.4.3 Eagle Pharmaceuticals Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Eagle Pharmaceuticals News
11.5 APOTEX
11.5.1 Company Details
11.5.2 Pemetrexed Drug Product Offered
11.5.3 APOTEX Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 APOTEX News
11.6 Qilu Pharmaceutical
11.6.1 Company Details
11.6.2 Pemetrexed Drug Product Offered
11.6.3 Qilu Pharmaceutical Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Qilu Pharmaceutical News
11.7 Biocon
11.7.1 Company Details
11.7.2 Pemetrexed Drug Product Offered
11.7.3 Biocon Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Biocon News
...
12 Research Findings and Conclusion
